KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Diluted Average): 2010-2025

Historic Shares Outstanding (Diluted Average) for Pacira BioSciences (PCRX) over the last 11 years, with Sep 2025 value amounting to $45.7 million.

  • Pacira BioSciences' Shares Outstanding (Diluted Average) fell 1.17% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year decrease of 1.17%. This contributed to the annual value of $46.2 million for FY2024, which is 11.03% down from last year.
  • As of Q3 2025, Pacira BioSciences' Shares Outstanding (Diluted Average) stood at $45.7 million, which was down 0.30% from $45.9 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Diluted Average) peaked at $52.5 million during Q2 2022, and registered a low of $45.6 million during Q4 2021.
  • Over the past 3 years, Pacira BioSciences' median Shares Outstanding (Diluted Average) value was $46.5 million (recorded in 2025), while the average stood at $48.7 million.
  • Per our database at Business Quant, Pacira BioSciences' Shares Outstanding (Diluted Average) grew by 14.63% in 2022 and then declined by 11.14% in 2024.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Shares Outstanding (Diluted Average) stood at $45.6 million in 2021, then climbed by 1.99% to $46.5 million in 2022, then grew by 11.69% to $52.0 million in 2023, then dropped by 11.03% to $46.2 million in 2024, then fell by 1.17% to $45.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $45.7 million in Q3 2025, compared to $45.9 million in Q2 2025 and $46.5 million in Q1 2025.